Eligible AACR 2019 Annual Meeting Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 12 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 9 10 11 12 presentations: 1 to 25 of 279
Introduction
Padmanee Sharma
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2019 on April 2, 2019 8:15 AM-10:15 AM
T-cell therapy targeting unique cancer mutations
Steven A Rosenberg
National Cancer Inst., Bethesda, MD, United States
from AACR Annual Meeting 2019 on April 2, 2019 8:15 AM-10:15 AM
Redirecting T cells for cancer immunotherapy using next-generation bispecific antibodies and fusion proteins
Pablo Umana
Roche Innovation Center Zurich, Zurich, Switzerland
from AACR Annual Meeting 2019 on April 2, 2019 8:15 AM-10:15 AM
Taming the beast: Strategies to target the immune-suppressive macrophage to enhance cancer immune therapy
Judith A Varner
UCSD Moores Cancer Ctr., La Jolla, CA, United States
from AACR Annual Meeting 2019 on April 2, 2019 8:15 AM-10:15 AM
Mismatch repair deficiency: A connection between the immune system and cancer genetics
Dung T Le
Johns Hopkins Sidney Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
from AACR Annual Meeting 2019 on April 2, 2019 8:15 AM-10:15 AM
Wrap-up and opportunities for the future
Padmanee Sharma
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2019 on April 2, 2019 8:15 AM-10:15 AM
Introduction
Silvia C Formenti
Weill Cornell Medical College, New York, NY, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:45 PM
Neoadjuvant immuno-radiotherapy (NIRT) in head and neck cancer: Phase I/Ib study of combined PD-1/SBRT prior to surgical resection
Rom Leidner
EACRI - Providence Cancer Center, Portland, OR, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:45 PM
Discussant
Christine H Chung
Moffitt Cancer Center, Tampa, FL, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:45 PM
Phase (Ph) I/II study of MBG453± spartalizumab (PDR001) in patients (pts) with advanced malignancies
Giuseppe Curigliano
Istituto Europeo di Oncologia IRCCS, Milan, Italy
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:45 PM
Discussant
David S Hong
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:45 PM
Gilteritinib significantly prolongs overall survival in patients with FLT3-mutated (FLT3mut+) relapsed/refractory (R/R) acute myeloid leukemia (AML): Results from the Phase III ADMIRAL trial
Alexander E Perl
Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:45 PM
Discussant
Tapan M. Kadia
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:45 PM
Phase I dose-escalation study of endoscopic intratumoral injection of OBP-301 (telomelysin) with radiotherapy in esophageal cancer patients unfit for standard treatments
Toshiyoshi Fujiwara
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:45 PM
Discussant
Geoffrey Y Ku
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:45 PM
A journey from phosphotyrosine to phosphohistidine with unexpected links to pancreatic cancer and liver cancer along the way
Tony Hunter
Salk Institute, La Jolla, CA, United States
from AACR Annual Meeting 2019 on April 2, 2019 7:00 AM-8:00 AM
A-to-I RNA editing in cancer
Erez Y Levanon
Bar-Ilan University, Ramat-Gan, Israel
from AACR Annual Meeting 2019 on April 2, 2019 7:00 AM-8:00 AM
Defining and targeting malignant brain tumor hierarchies
Peter B Dirks
The Hospital for Sick Children, Toronto, ON, Canada
from AACR Annual Meeting 2019 on April 2, 2019 7:00 AM-8:00 AM
Overcoming resistance to antibody-targeted cancer immunotherapy
Louis M Weiner
Georgetown Lombardi Comp. Cancer Ctr., Washington, DC, United States
from AACR Annual Meeting 2019 on April 2, 2019 7:00 AM-8:00 AM
Engaging and involving patients in translational cancer research
Bodour Salhia
University of Southern California, Los Angeles, CA, United States
from AACR Annual Meeting 2019 on April 2, 2019 7:00 AM-8:00 AM
New single-cell methods for oncology and immuno-oncology
James R Heath
California Inst. of Technology, Pasadena, CA, United States
from AACR Annual Meeting 2019 on April 2, 2019 7:00 AM-8:00 AM
Next-generation characterization and functional mapping of the cancer cell line encyclopedia: Implications for targeting dysregulated metabolism in cancer
William R. Sellers
Broad Institute, Cambridge, MA, United States
from AACR Annual Meeting 2019 on April 2, 2019 7:00 AM-8:00 AM
Novel therapeutic strategies in multiple myeloma
Kenneth C Anderson
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2019 on April 2, 2019 7:00 AM-8:00 AM
Obesity: Changing the landscape for cancer risk in populations
Elizabeth A Platz
Johns Hopkins School of Public Health, Baltimore, MD, United States
from AACR Annual Meeting 2019 on April 2, 2019 7:00 AM-8:00 AM
Prostate cancer health disparity
Timothy R Rebbeck
Harvard School of Public Health, Boston, MA, United States
from AACR Annual Meeting 2019 on April 2, 2019 7:00 AM-8:00 AM
<< first | < prev page: of 12 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 9 10 11 12 presentations: 1 to 25 of 279